Phase 2/3 trial of structurally distinct prodrug fosgonimeton (Athira ATH-1017) missed primary endpoint in 2023 Product Specifications Format: capsules Strength: 10 mg per capsule Count: 30 capsules per bottle Purity: 98% (HPLC verified) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
The therapy can help alleviate common hangover symptoms such as headaches, nausea, and fatigue
Rather than promoting growth directly, it aims to clear dysfunctional cellular components that impede normal tissue renewal processes
first application at 30 min after surgery, last at 24 h before sacrifice
When fluids and electrolytes become imbalanced, your brain doesn't function as efficiently, which can contribute to headaches, mental fatigue, and difficulty concentrating